MUC5AC and cholangiocarcinoma: Tissue MUC5AC testing, specifically immature MUC5AC (CLH2-reactive), can distinguish malignant tissues (CCA) from healthy controls but not from benign or premalignant designs such as PSC, BilIN, and IPNB [90,93,99].